These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3710036)

  • 1. Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays.
    Gold LS; Ward JM; Bernstein L; Stern B
    Fundam Appl Toxicol; 1986 May; 6(4):677-90. PubMed ID: 3710036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
    Gold LS; Slone TH
    J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database.
    Gold LS; Slone TH; Bernstein L
    Environ Health Perspect; 1989 Feb; 79():259-72. PubMed ID: 2707207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
    Gold LS; Slone TH; Stern BR; Bernstein L
    Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996.
    Gold LS; Manley NB; Slone TH; Rohrbach L
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):527-600. PubMed ID: 10421768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenic risk assessment: comparison of estimated safe doses for rats and mice.
    Chen JJ; Gaylor DW
    Environ Health Perspect; 1987 Jun; 72():305-9. PubMed ID: 3622439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the report: correlation between carcinogenic potency and the maximum tolerated dose: implications for risk assessment.
    Krewski D; Gaylor DW; Soms AP; Szyszkowicz M
    Risk Anal; 1993 Aug; 13(4):383-98. PubMed ID: 8234946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity.
    Dybing E; Sanner T; Roelfzema H; Kroese D; Tennant RW
    Pharmacol Toxicol; 1997 Jun; 80(6):272-9. PubMed ID: 9225363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data.
    Goodman G; Wilson R
    Environ Health Perspect; 1991 Aug; 94():195-218. PubMed ID: 1954931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
    Nesnow S
    Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncertainty in cancer risk estimates.
    Gaylor DW; Chen JJ; Sheehan DM
    Risk Anal; 1993 Apr; 13(2):149-54. PubMed ID: 8502788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity profiles of carcinogenicity data: application in hazard identification and risk assessment.
    Jackson MA; Stack HF; Waters MD
    Mutat Res; 1997 Nov; 394(1-3):113-24. PubMed ID: 9434850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: in tribute to Cesare Maltoni and David Rall.
    Huff J
    Ann N Y Acad Sci; 2002 Dec; 982():208-30. PubMed ID: 12562639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys.
    Gold LS; Manley NB; Slone TH; Ward JM
    Toxicol Pathol; 2001; 29(6):639-52. PubMed ID: 11794380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further development of a multifactor potency scheme for chemical carcinogens.
    Nesnow S
    Cancer Detect Prev; 1995; 19(6):465-71. PubMed ID: 8925515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose for rodent bioassays.
    Gaylor DW; Gold LS
    Regul Toxicol Pharmacol; 1995 Aug; 22(1):57-63. PubMed ID: 7494904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982.
    Gold LS; de Veciana M; Backman GM; Magaw R; Lopipero P; Smith M; Blumenthal M; Levinson R; Bernstein L; Ames BN
    Environ Health Perspect; 1986 Aug; 67():161-200. PubMed ID: 3530736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.